Clinical observations on the value of adrenocortical therapy in the Guillain-Barré symdrome.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000328:Adult; D002556:Cerebrospinal Fluid Proteins; D002675:Child, Preschool; D004569:Electroencephalography; D004576:Electromyography; D005158:Facial Paralysis; D005260:Female; D006801:Humans; D008875:Middle Aged; D011128:Polyradiculopathy / Q000188:drug therapy*
D002556:Cerebrospinal Fluid Proteins; D000324:Adrenocorticotropic Hormone